statistiche ricercatore

Continente	#
EU - Europa	662
NA - Nord America	479
AS - Asia	441
Continente sconosciuto - Info sul continente non disponibili	48
SA - Sud America	25
AF - Africa	18
Totale	1.673

Nazione	#
US - Stati Uniti d'America	452
DE - Germania	304
CN - Cina	133
SG - Singapore	125
IT - Italia	97
GB - Regno Unito	94
BD - Bangladesh	73
RU - Federazione Russa	31
SE - Svezia	30
HK - Hong Kong	26
BR - Brasile	21
FR - Francia	21
IN - India	21
VN - Vietnam	21
CA - Canada	19
NL - Olanda	19
IE - Irlanda	16
DK - Danimarca	14
FI - Finlandia	14
TR - Turchia	12
CI - Costa d'Avorio	11
KR - Corea	6
ID - Indonesia	4
MX - Messico	4
UA - Ucraina	4
BE - Belgio	3
CH - Svizzera	3
CZ - Repubblica Ceca	3
IR - Iran	3
JP - Giappone	3
PH - Filippine	3
AR - Argentina	2
AT - Austria	2
CR - Costa Rica	2
KE - Kenya	2
PL - Polonia	2
TW - Taiwan	2
ZA - Sudafrica	2
AZ - Azerbaigian	1
CO - Colombia	1
DZ - Algeria	1
EC - Ecuador	1
ES - Italia	1
GP - Guadalupe	1
HN - Honduras	1
HU - Ungheria	1
IL - Israele	1
IQ - Iraq	1
LB - Libano	1
MY - Malesia	1
NO - Norvegia	1
PK - Pakistan	1
SA - Arabia Saudita	1
SC - Seychelles	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
TH - Thailandia	1
TN - Tunisia	1
UZ - Uzbekistan	1
Totale	1.625

Nome	#
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study	409
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study	300
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study)	240
Moderate hypofractionation with simultaneous integrated boost in prostate cancer: long-term results of a phase I-II study	225
Salvage therapy of small volume prostate cancer nodal failures : a review of the literature	179
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups	161
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent	159
Totale	1.673

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	99	0	0	0	4	6	7	12	13	14	7	6	30
2022/2023	106	14	11	11	14	10	16	2	7	14	0	6	1
2023/2024	238	1	10	5	5	19	4	36	36	15	33	38	36
2024/2025	332	40	47	33	33	15	6	5	16	14	30	41	52
2025/2026	476	45	46	42	48	33	30	42	13	33	24	74	46
2026/2027	70	39	31	0	0	0	0	0	0	0	0	0	0
Totale													1.673

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca